Scant attention has been paid to evaluating differences in the prevalence of comorbidities and diabetes-related complications in familial versus sporadic type 1 diabetes (1). Knowledge gains in this area could advance the development of risk prediction tools and tailored interventions for preventing or delaying onset of comorbidities or diabetes-related complications in high-risk patient subgroups.
Patiëntvoorbeelden m.b.t. vergoeding
- ten laste van verzekeraar
- geen vergoeding door verzekeraar